Physician profile
Mark E Schmidt
NPI 1245281161
$1,278.25
in general payments reported to CMS, 2019-2025
17 companies · $615 in 2025
The $615 reported for 2025 was more than what 82% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.30 · 2020: $133 · 2021: $23.08 · 2022: $141 · 2023: $111 · 2024: $186 · 2025: $615.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $692 · Travel and Lodging: $220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $691.62 |
| Travel and Lodging | $219.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $480.33 | 2025 | |
| Abbvie INC. | $292.07 | 2022-2025 | Lumigan, Alphagan P, Vuity |
| Novartis Pharmaceuticals Corporation | $74.57 | 2019-2020 | |
| Bausch & Lomb Americas INC. | $50.95 | 2022-2025 | Xiidra, Miebo |
| Stryker Corporation | $48.31 | 2025 | Flowtriever |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $41.74 | 2019-2020 | |
| Dompe US, INC. | $37.16 | 2019-2025 | Oxervate |
| Abiomed | $35.64 | 2024 | Impella |
| Glaukos Corporation | $34.68 | 2024 | Idose |
| Alcon Vision LLC | $30.41 | 2024 | Rocklatan |
| Oyster Point Pharma, INC. | $25.58 | 2022 | |
| Shire North American Group INC | $23.93 | 2019 | |
| Ivantis, INC | $23.12 | 2020 | |
| Allergan, INC. | $23.08 | 2021 | |
| Aerie Pharmaceuticals, INC. | $20.34 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $19.11 | 2024 | Vevye |
| Sun Pharmaceutical Industries INC. | $17.23 | 2023 | Cequa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Schmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.